RAPT: RAPT Therapeutics Company Short-Term Debt
RAPT Therapeutics, Inc. (RAPT) specializes in developing innovative tools to strengthen immune defense. The quotes provided below on GURU.Markets capture the 0.00 metric. The company is implementing automated molecule screening to accelerate drug discovery. However, a lack of profitability and the risk of trial termination due to adverse reactions render the issuer's financial position extremely vulnerable and unstable.
Metric breakdowns and analytics for RAPT Therapeutics Inc. (RAPT)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital RAPT Therapeutics, Inc.|RAPT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity RAPT Therapeutics, Inc.|RAPT - Company Total Debt|Debt to Book Capitalization Ratio RAPT Therapeutics, Inc.|RAPT - Company Long-Term Liabilities|Company Current Liabilities RAPT Therapeutics|Quick Liquidity rapt.com
- net income and valuation multiples indicators:
Initial company analysis:RAPT - RAPT Therapeutics
Short-term debts reflect the total obligations of the company with a maturity of up to one year. An increase in this metric indicates rising borrowing costs and a risk of liquidity shortages. By analyzing the company's short-term liabilities, an investor assesses the resilience of the liability structure to external shocks. For RAPT Therapeutics, Inc. (RAPT), this is critical during raw material supply disruptions. A stable chart minimizes the threat of cash flow gaps when conducting costly clinical trials.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB - Company Short-Term Debt|Company Short-Term Loans and Borrowings ZBIO (Zenas Corp)|IMNM: Company Short-Term Debts|gossamerbio.com (GOSS) - Company Short-Term Debts|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|Septerna, Inc. - Current Liabilities|Company Current Liabilities PVLA (Pieris Pharmaceuticals Inc)|Amount of Current Liabilities SVRA|Rigel Pharmaceuticals - Company Current Liabilities|Company Short-Term Loans and Borrowings ANAB|ATXS: Company Current Liabilities|enGene Holdings Inc - Amount of Current Liabilities|JBIO: Company Short-Term Debts|Aclaris Therapeutics, Inc - Company Short-Term Loans and Borrowings|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|Short-Term Debt tizianalifesciences.com TLSA|Company Short-Term Debt Cabaletta Bio (CABA)|VTYX (Ventyx Biosciences Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts THTX (Theratechnologies Inc)|Company Short-Term Debts Avalo Therapeutics Inc AVTX|ELDN - Company Short-Term Debt|Current Liabilities AGEN|CLYM: Company Short-Term Debts|Short-Term Debt zurabio.com (ZURA)|Company Current Liabilities ATYR|Company Short-Term Debts Adagene Corp|Company Current Liabilities IMA (ImageneBio Inc)|Amount of Current Liabilities STTK|Company Short-Term Debts EQ (Equillium)|Short-Term Debt Volume Connect Biopharma Holdings (CNTB)|Immunic Inc - Company Short-Term Debts|Atara Biotherapeutics (ATRA) - Company Current Liabilities|inflarx.de (IFRX) - Company Short-Term Debt|XFOR - Short-Term Debt Volume|Company Current Liabilities ACET|CELU: Company Short-Term Loans and Borrowings|Company Short-Term Debts INMB|Short-Term Debt Volume Barinthus Biotherapeutics Corp|Company Short-Term Debt Kezar Life Sciences KZR|SABS: Company Short-Term Indebtedness|Akari Therapeutics Plc - Company Short-Term Debts|Enlivex Therapeutics (ENLV) - Company Current Liabilities|QTTB (q32bio.com) - Company Current Liabilities|GOVX - Short-Term Debt Volume|Company Short-Term Debt Edesa Biotech, Inc.|IBIO: Company Short-Term Loans and Borrowings|Company Short-Term Debts CARM|Company Short-Term Debts XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCWB (HCW Biologics, Inc.) - Current Liabilities|APVO: Company Current Liabilities|aimimmuno.com - Amount of Current Liabilities|aditxt.com (ADTX) - Company Short-Term Debt|Current Liabilities GRI (GRI Bio Inc)|XRTX (XORTX) - Company Short-Term Debts|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|Company Short-Term Loans and Borrowings CALI|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Current Liabilities ITOS|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debts TCBP|Short-Term Debt Volume Third Harmonic Bio Inc